Insider Transactions in Q4 2025 at Hologic Inc (HOLX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 11
2025
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,679
-0.46%
|
$494,246
$74.6 P/Share
|
|
Nov 11
2025
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
178
-0.13%
|
$13,172
$74.6 P/Share
|
|
Nov 11
2025
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
181
-0.99%
|
$13,394
$74.6 P/Share
|
|
Nov 11
2025
|
Brandon Schnittker President, GYN Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
289
-1.6%
|
$21,386
$74.6 P/Share
|
|
Nov 11
2025
|
Jennifer M Schneiders President, Diag. Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
702
-1.65%
|
$51,948
$74.6 P/Share
|
|
Nov 11
2025
|
Essex D Mitchell Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,701
-2.11%
|
$125,874
$74.6 P/Share
|
|
Nov 11
2025
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,449
-0.94%
|
$107,226
$74.6 P/Share
|
|
Nov 11
2025
|
Anne M. Liddy General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
406
-1.4%
|
$30,044
$74.6 P/Share
|
|
Nov 10
2025
|
Stephen P Macmillan Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
169,582
+10.55%
|
-
|
|
Nov 10
2025
|
Jan Verstreken Group President, International |
BUY
Grant, award, or other acquisition
|
Direct |
16,823
+11.12%
|
-
|
|
Nov 10
2025
|
Benjamin Jordan Cohn Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,047
+21.66%
|
-
|
|
Nov 10
2025
|
Brandon Schnittker President, GYN Surgical |
BUY
Grant, award, or other acquisition
|
Direct |
12,113
+40.13%
|
-
|
|
Nov 10
2025
|
Jennifer M Schneiders President, Diag. Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
30,282
+41.56%
|
-
|
|
Nov 10
2025
|
Mark W. Horvath President, Breast & Skeletal |
BUY
Grant, award, or other acquisition
|
Direct |
13,458
+36.77%
|
-
|
|
Nov 10
2025
|
Essex D Mitchell Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,106
+36.87%
|
-
|
|
Nov 10
2025
|
Karleen Marie Oberton Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,741
+22.17%
|
-
|
|
Nov 10
2025
|
Anne M. Liddy General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
17,496
+37.65%
|
-
|
|
Nov 07
2025
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
50,405
-3.82%
|
$3,729,970
$74.1 P/Share
|
|
Nov 07
2025
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
1,420
-1.19%
|
$105,080
$74.1 P/Share
|
|
Nov 07
2025
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,078
-7.55%
|
$79,772
$74.1 P/Share
|
|
Nov 07
2025
|
Brandon Schnittker President, GYN Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
138
-2.26%
|
$10,212
$74.1 P/Share
|
|
Nov 07
2025
|
Jennifer M Schneiders President, Diag. Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
158
-1.27%
|
$11,692
$74.1 P/Share
|
|
Nov 07
2025
|
Essex D Mitchell Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,927
-10.48%
|
$290,598
$74.1 P/Share
|
|
Nov 07
2025
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,427
-7.91%
|
$697,598
$74.1 P/Share
|
|
Nov 07
2025
|
Anne M. Liddy General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
288
-2.45%
|
$21,312
$74.1 P/Share
|
|
Nov 04
2025
|
Stephen P Macmillan Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
83,589
+5.96%
|
-
|
|
Nov 04
2025
|
Karleen Marie Oberton Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,095
+12.54%
|
-
|
|
Nov 04
2025
|
Jan Verstreken Group President, International |
BUY
Grant, award, or other acquisition
|
Direct |
15,196
+11.32%
|
-
|
|
Nov 04
2025
|
Essex D Mitchell Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,116
+19.57%
|
-
|
|
Nov 04
2025
|
Mark W. Horvath President, Breast & Skeletal |
BUY
Grant, award, or other acquisition
|
Direct |
2,278
+19.05%
|
-
|
|
Nov 04
2025
|
Benjamin Jordan Cohn Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,656
+15.68%
|
-
|
|
Oct 20
2025
|
Christiana Stamoulis Director |
SELL
Open market or private sale
|
Direct |
7,402
-13.52%
|
$540,346
$73.07 P/Share
|
|
Oct 20
2025
|
Christiana Stamoulis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,402
+11.91%
|
$266,472
$36.04 P/Share
|